Bottom line
What is DEMCX's expense ratio?
DEMCX's expense ratio is 2.15%, or about $215 a year on every $10,000 invested. That is more expensive than 98% of emerging markets funds we track (median 1.02%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Mar 27, 2026
DEMCX fee table
| Net expense ratio | 2.15% |
|---|---|
| Gross expense ratio | 2.32% |
| Management fee | 1.13% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.19% |
| Fee waiver / reimbursement | -0.17% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Mar 27, 2026
What DEMCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DEMCX | $318 | $708 | $1,225 | $2,643 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.15% expense ratio costs roughly $107,800 in lost growth, versus about $56,400 for the median emerging markets fund (1.02%).